Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: comment on: Miedany et al. response letter: Beyond the symptoms: personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Volume 75, December 2025, 152844.

Seminars in arthritis and rheumatism·2026
Same author

Comment on: Miedany et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure.

Seminars in arthritis and rheumatism·2025
Same author

Early referral of patients with suspected polymyalgia rheumatica - A systematic review.

Seminars in arthritis and rheumatism·2023
Same author

Lifetime risk and genetic predisposition to post-traumatic OA of the knee in the UK Biobank.

Osteoarthritis and cartilage·2023
Same author

Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes.

Journal of immunological methods·2020
Same author

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Annals of the rheumatic diseases·2013
Same journal

Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study.

Reumatismo·2026
Same journal

Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study.

Reumatismo·2026
Same journal

Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

Reumatismo·2026
Same journal

Is there still someone laughing at Christopher Columbus?

Reumatismo·2026
Same journal

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue.

Reumatismo·2026
Same journal

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Reumatismo·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos
05:32

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos

Published on: December 7, 2018

9.7K

Comorbidity in polymyalgia rheumatica.

C Chatzigeorgiou1, S L Mackie

  • 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds. umcch@leeds.ac.uk.

Reumatismo
|March 29, 2018
PubMed
Summary
This summary is machine-generated.

Polymyalgia rheumatica (PMR) management in older adults is challenged by comorbidities, often linked to glucocorticoid therapy. Understanding these comorbidities is crucial for effective treatment and healthcare planning.

Keywords:
CancerParaneoplastic syndromePolymyalgia rheumaticaSystematic review.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.8K

Related Experiment Videos

Last Updated: Feb 12, 2026

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos
05:32

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos

Published on: December 7, 2018

9.7K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

10.8K

Area of Science:

  • Rheumatology
  • Geriatrics
  • Clinical Medicine

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent inflammatory rheumatic disease in the elderly.
  • Long-term oral glucocorticoid therapy is the standard treatment for PMR.
  • Patient management is frequently complicated by comorbidities, which can arise from shared risk factors, the disease itself, or treatment side effects.

Purpose of the Study:

  • To highlight the clinical significance of comorbidities in PMR patients.
  • To emphasize the impact of glucocorticoid therapy on associated comorbidities.
  • To inform clinical decisions regarding treatment strategies and healthcare resource allocation.

Main Methods:

  • Review of existing literature on PMR and its associated comorbidities.
  • Analysis of the relationship between glucocorticoid therapy and specific comorbidities (cardiovascular, osteoporosis, metabolic, ocular).
  • Consideration of public health implications and future healthcare needs.

Main Results:

  • Comorbidities significantly complicate PMR management, particularly in older populations.
  • Cardiovascular disease, osteoporosis/fracture, metabolic, and ocular conditions are key comorbidities linked to glucocorticoid use.
  • Steroid-sparing therapies may be necessary for high-risk patients, necessitating specialist input.

Conclusions:

  • Effective management of PMR requires careful consideration of comorbidities and their relationship to glucocorticoid therapy.
  • Accurate comorbidity data is essential for future healthcare planning, especially with an aging population and predicted increase in PMR prevalence.
  • Specialist management may be required for patients at high risk of comorbidity exacerbation.